In the quest for adjunctive therapies for drug-resistant epilepsy, particularly in children with severe forms, music has emerged as a promising non-pharmacological intervention. Known for its potential to influence brain activity, Mozart's music—especially the Sonata for Two Pianos in D major, K448—has been linked to reductions in interictal EEG discharges and clinical seizures in various studies. A 2015 prospective, open-label study by Giangennaro Coppola and colleagues explored this further by applying the Tomatis method—a sound therapy approach developed by Alfred Tomatis that filters music to emphasize high frequencies (>3000 Hz)—using a selection of Mozart's compositions. Study Design and Participants The research focused on 11 outpatients (7 males, 4 females) aged 1. 5 to 21 years (mean age: 11. 9 years), all diagnosed with drug-resistant epileptic encephalopathy and severe to profound intellectual disability associated with cerebral palsy. Antiepileptic drug regimens remained unchanged throughout the trial to isolate the effects of the music intervention. Participants listened to filtered Mozart compositions for 2 hours daily over 15 days, totaling 30 hours. Listening sessions could be distributed flexibly based on each patient's habits and compliance, making the approach practical for this challenging population. Key Results: Seizure Reduction The outcomes were encouraging:5 out of 11 patients (45. 4%) experienced a ≥50% reduction in seizure frequency. Specifically: 2 patients saw 50-75% fewer seizures, and 3 had 75-89% reductions. Overall, the group showed a -51. 5% decrease in total seizures during the 15-day therapy compared to baseline. In the two weeks post-treatment, the reduction persisted at -20. 7%. These responders also reported notable improvements in nighttime sleep quality and daytime behavior, including reduced auto-/hetero-aggression, irritability, and hyperactivity. The Tomatis Method and High-Frequency Filtering The Tomatis method stands out by processing Mozart's music to prioritize higher frequencies, believed to stimulate the ear and brain more effectively for auditory processing and neural integration. This aligns with prior evidence on K448's antiepileptic properties while broadening the musical selection to improve adherence in children. Implications for Drug-Resistant Epilepsy For children with severe, refractory epilepsy—often compounded by intellectual disabilities and behavioral challenges—this short-term intervention offered meaningful benefits without side effects. While open-label and small-scale, the study adds to the growing body of evidence supporting the "Mozart effect" in epilepsy management. Researchers suggest that Mozart's structured yet harmonious compositions may modulate neural networks, potentially mirroring resonance or dopaminergic pathways. The sustained post-treatment effect hints at lasting neuroplastic changes. This work underscores the potential of accessible, non-invasive therapies like filtered Mozart listening as complements to traditional treatments. Larger, controlled trials could further validate and refine this approach, offering hope for improved quality of life in one of neurology's most challenging conditions. FAQs